Drugs to be Discontinued by FDA

Drugs to be Discontinued
Companies are required under 21 CFR 314.81(b)(3)(iii) to provide FDA with a six month advance notice of the discontinuation of sole source products that are life-supporting, life-sustaining or for use in the prevention of a debilitating disease or condition. From time to time, FDA also receives notification for other products. These discontinuations are provided below for informational purposes only.

abrir aquí para acceder al listado (extenso):
Drugs to be Discontinued